Navigation Links
Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
Date:8/19/2007

Pharmion

Pharmion is a biopharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements, including summary statements relating to top line results of the Vidaza Survival Study and summary statements relating to the potential efficacy of Vidaza based on those results. Such statements are based on current expectations and beliefs only and are subject to risks and uncertainties, many of which are beyond our control, that could cause the final results to differ significantly from the results summarized by such statements. Actual results could differ materially depending on a number of factors, and we caution investors not to place undue reliance on the forward-looking statements contained in this press release. In particular, there can be no guarantee that topline results from the clinical trial discussed in this press release will be confirmed upon full analysis of the results of the Vidaza Survival Study and additional information relating to the safety, efficacy or tolerability of Vidaza may be discovered upon further analysis of data from the Vidaza Survival Study or analysis of additional data from other ongoing Vidaza clinical trials. Furthermore, even if these topline results are confirmed upon full analysis of the study, we cannot guarantee that Vidaza will be approved for marketing in a timely manner, if at all, by regulatory authorities in the EU or that information from the stu
'/>"/>

SOURCE Pharmion Corporation

Copyright©2007 PR Newswire.

3

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
2. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , COVINA, Calif., Nov. 30 Stem...ercialization agreement with Academia Sinica, the ...tary methods and Intellectual Property (IP) relate...ls. This method and IP was pioneered by a team le...ademia Sinica. Professor Lin is currently the exc...
(Date:11/30/2009)..., BLOOMFIELD HILLS, Mich., Nov. 30 /PRNewswire/ ...pping site dedicated exclusively to products appro...s Account (FSA/HSA) claims. The site is also the ...ounter medications, saving shoppers up to 75 perce...urce helps cure two common healthcare headaches - ...
(Date:11/30/2009)... , BOZEN, Italy, November 30 /PRNewswire/ ...veil TPNstation,s development plans and product sp..."Totally Automated Parenteral,Nutrition", a new ke...to be,showcased at Las Vegas, ASHP (Booth # 114). ...m our customers to the,TPNstation,s blueprints and...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3NGA Chair Vermont Governor Douglas to Speak on States Role in Health Care Reform at the National Press Club on September 17 56665 1NGA Chair Vermont Governor Douglas to Speak on States Role in Health Care Reform at the National Press Club on September 17 56665 2Bright Beginnings 28R 29 NeoCare 28TM 29 Value Priced Weight Gain Infant Formula Now Available Online at www pbmstore com 56662 1Bright Beginnings 28R 29 NeoCare 28TM 29 Value Priced Weight Gain Infant Formula Now Available Online at www pbmstore com 56662 2SEQUENOM Announces Partnership With GeneWorks for Sales 26 Marketing of MassARRAY Systems and Applications in Australia 13949 1SEQUENOM Announces Partnership With GeneWorks for Sales 26 Marketing of MassARRAY Systems and Applications in Australia 13949 2SEQUENOM Announces Partnership With GeneWorks for Sales 26 Marketing of MassARRAY Systems and Applications in Australia 13949 3SEQUENOM Announces Partnership With GeneWorks for Sales 26 Marketing of MassARRAY Systems and Applications in Australia 13949 4
(Date:11/30/2009)... The launch of Invivo Corporation,s...irst FDA-cleared, fully-automated morphological sy...st of suspicious breast lesions. The ONCAD system ...ciety of North America 2009 Annual Meeting in Chic...xperts in breast MRI, ONCAD for DynaCAD uses a pat...
(Date:11/30/2009)... results in animals , , MONDAY, Nov. 3...uggest that stem cells from transplanted human-der...ng and heart disorders. , Scientists already k...long list of different kinds of cells in the labor...nter in Seoul, Korea, co-author of one of the stud...
(Date:11/30/2009)...wire/ --- Salon Leau announced today they are host...o raise funds and create positive impact in the fi...eds from each haircut and or color will be donated...Salon Leau has been serving the posh Washington DC... widely recognized for her innovation in color, cu...
(Date:11/30/2009)... PHILADELPHIA, Pennsylvania, November 30 /PRNews...From Elsevier,s Top Thought Leaders Provide Insigh... Elsevier, a world leader in healthcare publicati...c health record (EHR) integrated solutions, today,...n Recovery and Reinvestment,Act (ARRA) updates and...
(Date:11/30/2009)...ir response to a "cocaine-cues" video, active coca...ivity in brain regions linked to drug craving, acc...ergy,s Brookhaven National Laboratory. The results...age , suggest that clinical interventions designed...lp cocaine abusers stop using drugs and avoid rela...
Breaking Medicine News(10 mins):Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3
... Zealand: Though there have been improvements in m...ontract, yet it is considered inadequate, due to w...r general practitioners//. Proposed changes to mat...ociation's GP council, said "They are not seeing t...
... first drug proven to significantly improve the vi...n Friday//. The drug, Lucentis, is to treat ...where blood vessels behind the retina leak, worsen... to have the wet form of the disease. Lucent...
...orado: Ken Lay, the founder of Enron, who was admi...oronary, passed away, in the early morning due to ...ed mastermind behind the Enron scandal had succumb...10 counts of fraud and conspiracy on the investors...
...ew Health Canada document available with CanWest N...iation for patients //could "translate in the savi...ncers caused by X-rays kill 780 to 2,500 Canadians...ntly tested and their efficacy and safety remains ...
...wo-year-old boy in Bihar weighs an unbelievable 35...nt doctors to find out the cause. // Ayush be...id his father Kanhal Singh, who stays in Muzaffarp...hi where doctors said he was a normal child. They ...
... Supreme Court Wednesday criticised the central go...od they were on strike in May protesting quotas//i... be a "model employer". Conveying its disple...ld act like a model employer. When the doctors wer...
Other Medicine News:Health News:Government Pulled up for Denying Pay to Striking Medicos 2
Clearview EASY HCG
SureStep Propoxyphene (PPX)
COC/MAMPII/MOP/THC/AMPII/BAR/BZO300/MTD/TCA
SureStep AMP/COC/MAMP/OPI/THC
Medicine Products: